CF PharmTech, Inc. (02652) released its Monthly Return for Equity Issuer for the reporting period ended 30 November 2025, disclosing no changes in share capital. The company’s registered share capital remained at RMB 411,978,387, comprised of 302,223,586 H shares and 109,754,801 domestic shares, each with a par value of RMB 1. The total issued shares for both H shares and domestic shares also remained unchanged from the previous month, with neither treasury shares nor other convertible or share option arrangements reported during the period.
According to the announcement, relevant confirmations related to compliance with listing rules and regulatory requirements were completed, indicating no new share issuances, treasury share transactions, or other capital changes. The document was submitted on 04 December 2025, with all details reflecting conditions as of 30 November 2025.
Comments